Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Ticchioni

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Neuroimmunology|September 10, 2016
Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravisChristine Lebrun, Véronique Bourg, Saskia Bresch, et al.
The Journal of Biological Chemistry|April 12, 2003
CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosisLaurence Lamy, Michel Ticchioni, Alexandre K Rouquette-Jazdanian, et al.
JAMA Dermatology|May 30, 2014
Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areataEmeline Castela, Florence Le Duff, Catherine Butori, et al.
Neurology and Therapy|June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum DisordersChristine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.
Cancer|February 5, 2008
Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemiaSören Lehmann, Seishi Ogawa, Sophie D Raynaud, et al.
Journal of Neurology|June 9, 2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatmentCharlotte Héraud, Saskia Bresch, Véronique Bourg, et al.
The Journal of Infection|September 1, 2004
Apoptosis of naive CD4+ T-cells from HIV-infected patients with poor immune response to HAART is enhanced in vitro by steroidPierre-Marie Roger, Isabelle Perbost, Michel Ticchioni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 26, 2021
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia GravisCaroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, et al.
Frontiers in Immunology|March 23, 2023
Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT studySabrina Manni, Caroline Ruetsch, Roxane Fabre, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2003
Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptionsPierre-Marie Roger, Jacques Durant, Michel Ticchioni, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Neuroimmunology|September 10, 2016
Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravisChristine Lebrun, Véronique Bourg, Saskia Bresch, et al.
The Journal of Biological Chemistry|April 12, 2003
CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosisLaurence Lamy, Michel Ticchioni, Alexandre K Rouquette-Jazdanian, et al.
JAMA Dermatology|May 30, 2014
Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areataEmeline Castela, Florence Le Duff, Catherine Butori, et al.
Neurology and Therapy|June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum DisordersChristine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.
Cancer|February 5, 2008
Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemiaSören Lehmann, Seishi Ogawa, Sophie D Raynaud, et al.
Journal of Neurology|June 9, 2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatmentCharlotte Héraud, Saskia Bresch, Véronique Bourg, et al.
The Journal of Infection|September 1, 2004
Apoptosis of naive CD4+ T-cells from HIV-infected patients with poor immune response to HAART is enhanced in vitro by steroidPierre-Marie Roger, Isabelle Perbost, Michel Ticchioni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 26, 2021
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia GravisCaroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, et al.
Frontiers in Immunology|March 23, 2023
Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT studySabrina Manni, Caroline Ruetsch, Roxane Fabre, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2003
Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptionsPierre-Marie Roger, Jacques Durant, Michel Ticchioni, et al.
Pageof 5